Document:

EX-10.1

 Exhibit 10.1 
  

 
 October 24, 2014 
 Lisa
Evans 
 evanslisac@yahoo.com 
 Dear Lisa: 

It gives me great pleasure to confirm in writing the offer of employment that we have discussed. I am extremely excited at the prospect of partnering with you,
and believe that your leadership style, demonstrated retail acumen and broad experience are a tremendous fit with our Company’s culture, our senior management group and merchandising team. As importantly, I believe that Gordmans offers you the
opportunity to optimize your tremendous skills and potential, immediately and well into the future. Here are the specifics of our offer: 
 Start
Date: TBD, on or about January 5th, 2015 
 Position: EVP Chief Merchandising Officer

 Supervisor: Andy Hall, President & CEO 

Salary: You will receive a biweekly base salary of $15,384.62 (26 biweekly periods per year) which, when annualized, would equate to $400,000.00.
Paydays are every other Friday. 
 Annual Bonus: You will be eligible to participate in the Incentive Compensation Program for Officers according to
the terms of that program. The annual bonus target for your position, assuming the performance thresholds are reached, is approximately 45% of the base salary in effect at the start of the fiscal year, with a maximum of 90%. 

Equity Participation: On your start date, you will be granted options to acquire 70,000 shares of the Company’s common stock, pursuant to a
Non-Qualified Stock Option Agreement. The exercise price of the stock options will be equal to the market price on the date of grant and the rate of vesting will be 25% per year beginning on the first anniversary of the grant date, based
upon the provisions of the Non-Qualified Stock Option Agreement.
 During our scheduled Long Term Incentive review period in June of 2015, you will also be
granted equity instruments valued at 70% of your base salary. These instruments will be a combination of restricted stock and stock options to acquire shares of the Company’s common stock, pursuant to a Restricted Stock Agreement and a
Non-Qualified Stock Option Agreement issued under the 2010 Omnibus Incentive Compensation Plan. For example, with your base salary of $400,000, your equity participation would be valued at $280,000.00. For purposes of determining the number of
shares of restricted stock and stock options, we value our restricted stock to be equal to 95% of the FMV of the Company’s stock for the 30 days prior to the date the grants are approved by our Board of Directors

 
and the options are valued at 50% of the FMV for the 30 days prior to the approval date. The exercise price of the stock options, however, will be equal to the actual market price on the
date of grant. The rate of vesting for the stock options will be 25% per year beginning on the first anniversary of the grant date, based upon the provisions of the Restricted Stock and Non-Qualified Stock Option agreements, as applicable.

The formal Restricted Stock and Non-Qualified Stock Option agreements will be drafted and sent to you for your review and signature as soon as
administratively possible after the date of grant, which is pending board of directors approval. 
 As an Officer-level associate with Gordmans, you will be
eligible for additional annual equity awards at the discretion of Gordmans management. 
 Relocation: Your eligible expenses in relocation and
commuting from Atlanta to Omaha will be reimbursed in accordance with company policy. The details of this policy are explained more fully in the separate documents titled Relocation Repayment Agreement and Gordmans Relocation Policy Tier 3
Homeowner. Gordmans will cover a maximum of $120,000.00 in eligible expenses including house hunting trips, closing costs, down payments, commissions, travel expenses while commuting, apartment rent expenses and moving van expenses. Eligible
expenses will be covered up to three years from your start date. 
 Benefits: During the 60-day waiting period for benefits, Gordmans will subsidize
any COBRA healthcare payments that you may be making to your previous employer such that your net cost is no more than you would pay as an active participant under our healthcare plan. Note that officers are eligible for four weeks of vacation each
year. A complete listing of benefits and eligibility requirements will be provided. 
 Performance Review: Your performance will be formally
evaluated at the end of each fiscal year against the objectives agreed to by you and your supervisor. Your salary will be adjusted annually according to the degree of attainment of those objectives. You will receive a pro-rated performance review
(based on length of service) on or about May 1, 2016 and annually thereafter. 
 Separation of Employment: Our relationship will be based on
mutual respect and consent, and therefore will continue only as long as both parties find the relationship to be satisfactory. Accordingly, you are free to terminate your employment with proper notice whenever you feel it would be in your best
interest to do so. By the same token, Gordmans reserves the right to terminate employment whenever, in its discretion, it feels necessary to do so. This is known as employment “at-will.” If, however, your employment is terminated by
Gordmans without cause or within nine months of a change in control, the location of your place of work is moved more than 50 miles, or the position and scope of your responsibilities are significantly reduced, then, subject to execution of a
release of claims against us, you will receive salary continuation up to the earlier of (a) the period of time equal to the number of months you were employed by Gordmans, not to exceed six months, and (b) the date on which you are
employed by a third party. Additionally, you will receive continued medical and dental coverage during this period. If termination occurs for cause, you will not be entitled to any compensation whatsoever from Gordmans beyond the last day worked.
“Cause” for termination of employment is defined, in the reasonable opinion of the President & CEO of the Company, as (i) willful or deliberate misconduct as an employee of the Company; (ii) misappropriation or misuse of
the Company’s trade secrets or proprietary information, including the disclosure of confidential information to others; (iii) any act of embezzlement or fraud against the Company or its customers or vendors, or dishonesty;
(iv)

 
any conduct which is or may be injurious to the Company (including its reputation), its customers, or its vendors; (v) any immoral or illegal conduct; and (v) negligence which manifests
culpability, wrongful intent, evil design, or substantial disregard of Gordmans’ interests or of your duties and obligations. You will not be entitled to any severance or payment beyond your last day worked if you terminate your employment with
Gordmans. 
 Business Ethics/Conflict of Interest: Please carefully read the enclosed Business Ethics/Conflict of Interest policy and sign the
Handbook Acknowledgement. This offer of employment, and your continuing employment, is conditional upon the absence of any conflicts of interest as defined in our policy. 

Identity/Employment Eligibility: This offer of employment is contingent upon the favorable results of your background check. It is also contingent on
your ability to provide appropriate original documentation verifying your identity and eligibility to work in the United States as required by The Immigration Reform and Control Act. The attached “List of Acceptable Documents” outlines the
documentation that we are required to review. Please bring one document from List A OR one document from List B AND one document from List C on your first day of employment. Should you be unable to provide the necessary documents within the
government mandated 72 hours, your employment may be terminated. 
 This letter contains all the specifics of our offer and any changes must be in writing
and signed by Gordmans. Please indicate your formal acceptance of this offer of employment with Gordmans by returning a signed copy of this letter to me as soon as possible. Please scan the signed letter and acknowledgement to Roger Glenn at
roger.glenn@gordmans.com. 
 Lisa, if you have any questions about the specifics of this offer, please don’t hesitate to call me. We are
very confident that your talents and experience will enable you to make a significant positive impact on the Gordmans shopping experience as well as the work experience. Once again, I am extremely enthusiastic about the prospect of working
together, as is our entire management team, and greatly appreciate your giving this offer every consideration. 
 Best regards, 

Andy Hall 
 Andy Hall 

ACCEPTED AND AGREED: 
  

							
	Signature	  	 /s/ Lisa Evans
	  	Date	  	 November 20, 2014

		  	Lisa Evans	  		  	

 LIST OF ACCEPTABLE DOCUMENTS 
  

					
	 List A
	  	 List B
	  	 List C

	Documents that Establish Both Identity and Employment Eligibility	  	Documents that Establish Identity	  	Documents that Establish Employment Eligibility
	  

1.     U.S. Passport or U.S. Passport card

 
 2.     Certificate of
U.S. Citizenship (INS Form N-550 or N-561).
  

3.     Certificate of Naturalization (INS Form N-550 or N-570).

 
 4.     Unexpired foreign
passport, with I-551 stamp or attached INS Form I-94 indicating unexpired employment authorization.
  

5.     Alien Registration Receipt Card with photograph (INS Form I-151 or I-551).

 
 6.     Unexpired
Temporary Resident Card (INS Form I-668).
  

7.     Unexpired Employment Authorization Card (INS Form I-668A).

 
 8.     Unexpired Reentry
Permit (INS Form I-327).
  

9.     Unexpired Refugee Travel Document (INS Form I-571).

 
 10.   Unexpired Employment
Authorization Document issued by the INS which contains a photograph (INS Form I-688B).
	  	  

1.     Driver’s license or ID card by a state or outlying possession of the U.S.
provided it contains a photograph or information such as name, date of birth, sex, height, eye color, and address.
  

2.     ID card issued by federal, state, or local government agencies or entities provided it
contains a photograph or information such as name, date of birth, sex, height, eye color, and address.
  

3.     School ID card with a photograph.

 
 4.     Voter’s
registration card.
  

5.     U.S. Military card or draft record.

 
 6.     Military
dependent’s ID card.
  

7.     U.S. Coast Guard Merchant Mariner Card.

 
 8.     Native American
tribal document.
  

9.     Driver’s license issued by a Canadian government authority.

 
 10.   School record or report
card.
  
 11.   Clinic, doctor, or
hospital record.
  

12.   Day-care or nursery school record.
	  	  

1.     U.S. Social Security Card issued by the Social Security Administration (other than a
card stating it is not valid for employment).
  

2.     Certification of Birth Abroad issued by the Department of State (Form FS-545 or Form
DS-1350).
  

3.     Original or certified copy of a birth certificate issued by a state, county, municipal
authority or outlying possession of the U.S. bearing an official seal.
  

4.     Native American tribal document.

 
 5.     U.S. Citizen ID
Card (INS Form I-197).
  

6.     ID Card for use of Resident Citizen in the U.S. (INS Form I-179).

 
 7.     Unexpired
employment authorization document issued by the INS (other than those listed under List A).EXHIBIT
4.1

 

FORM
OF warrant

 

To purchase ______________ shares of Common
Stock

of Immune Pharmaceuticals Inc. (the
"Company")

at a per share price and subject to the
terms detailed below

VOID AFTER 17:00 p.m. NY Standard Time on
the last day of the Warrant Period (as defined below)

 

THIS IS TO CERTIFY
THAT, ____________ (the "Holder"), is entitled to purchase from the Company, an aggregate of up to _________
shares of Common Stock of the Company, nominal value of USD 0.0001 per share (the "Warrant Shares") during the
Warrant Period under the terms hereof.

 

		1.	EXERCISE PRICE

 

The exercise price per Warrant Share (the
"Exercise Price") shall be equal to US$3.75 price per share.

 

		2.	EXERCISE OF WARRANT

 

		2.1.	Exercise. Exercise of the purchase rights represented by this Warrant may be made, in whole or
in part, at any time or times on or after the Commencement Date and on or before the Termination Date by delivery to the Company
(or such other office or agency of the Company as it may designate by notice in writing to the registered Holder at the address
of the Holder appearing on the books of the Company) notice of exercise, in the form attached hereto as Schedule 2.1
(the "Exercise Notice"). Within three (3) Trading Days following the date of exercise as aforesaid, the Holder
shall deliver the aggregate Exercise Price for the shares specified in the applicable Exercise Notice by wire transfer or cashier’s
check drawn on a United States bank. No ink-original Exercise Notice shall be required, nor shall any medallion guarantee (or other
type of guarantee or notarization) of any Exercise Notice form be required. Notwithstanding anything herein to the contrary, the
Holder shall not be required to physically surrender this Warrant to the Company. Partial exercises of this Warrant resulting in
purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. In the
event of any dispute or discrepancy, the records of the Company shall be controlling and determinative in the absence of manifest
error. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases.
The Company shall deliver any objection to any Exercise Notice within three (3) Business Day of receipt of such notice. The
Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph,
following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder
at any given time may be less than the amount stated on the face hereof.

 

		2.2.	Adjustment. The number of Warrant Shares purchasable upon the exercise of this Warrant and
the Exercise Price shall be subject to adjustment from time to time in the event of re-organization of the share capital, stock-split,
issuance of bonus shares, etc.

 

		2.3.	No Transferability. This Warrant and the Holder’s rights thereunder are not transferable
and/or assignable in any way. Exercise of this Warrant may be made only by the Holder.

 

		2.4.	No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares
shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to
purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction
in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

 

		3.	RIGHTS OF THE HOLDER

 

		3.1.	The Holder will not be entitled, as a Warrant holder, to vote or receive dividends or be deemed
the holder of the shares of the applicable class of Warrant Shares or any other securities of the Company which may at any time
be issuable on the exercise of this Warrant for any purpose, nor will anything contained herein be construed to confer upon the
Holder, as such, any of the rights of a shareholder of the Company or any right to vote for the election of directors or upon any
matter submitted to shareholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any
recapitalization, issuance of shares, reclassification of shares, change of par value, consolidation, merger, conveyance, or otherwise)
or to receive notice of meetings, or to receive dividends or subscription rights or otherwise until the Warrant will have been
exercised and the shares of the applicable class of Warrant Shares purchasable upon the exercise hereof will have become deliverable,
as provided herein. Upon the exercise of this Warrant, the Holder will be entitled to receive the same rights on the Warrant Shares
as will then be in effect with respect to the holders of such class of shares of the Company.

 

    	1

    	 

    

 

		4.	TERM AND TERMINATION

 

This
Warrant may be exercised, subject to the terms and conditions hereof, during the period commencing on  November 25, 2014
(the "Commencement Date") and terminating upon the the third anniversary of the Commencement Date
(the "Termination Date"). For the avoidance of any doubt, the Company shall not be required to provide the
Holder with a reminder or prior notice with respect to the Termination Date. The above period shall be referred to
hereinafter as the "Warrant Period". Notwithstanding anything to the contrary, this Warrant and all the
rights conferred hereby shall terminate and expire at the aforementioned time on the last day of the Warrant Period, unless
the Warrant was previously exercised.

 

		5.	MISCELLANEOUS

 

		5.1.	Loss, Theft, Destruction or Mutilation of Warrant. If this Warrant will be lost, stolen,
destroyed, or mutilated, the Company will execute and deliver to the Holder a replacement warrant of like date, tenor, and denomination
upon receipt by the Company of (a) evidence satisfactory to the Company of the occurrence of such event; (b) reimbursement of the
Company’s reasonably incidental expenses; and (c) (i) in the event of mutilation, upon surrender and cancellation of this
Warrant; or (ii) in the event of loss, theft, or destruction of this Warrant, of indemnity reasonably satisfactory to the Company.

 

		5.2.	Entire Agreement; Amendment. This Warrant sets forth the entire understanding of the parties
with respect to the subject matter hereof and supersedes all existing agreements among them concerning such subject matter. All
section headings herein are inserted for convenience only and shall not modify or affect the construction or interpretation of
any provision of this Warrant. No modification or amendment of this Warrant will be valid unless executed in writing by the Company
and the Holder.

 

		5.3.	Waiver. No failure or delay on the part of any of the parties in exercising any right, power
or privilege hereunder and/or under any applicable laws or the exercise of such right or power in a manner inconsistent with the
provisions of this Warrant or applicable law shall operate as a waiver thereof. Any waiver must be evidenced in writing signed
by the party against whom the waiver is sought to be enforced.

 

		5.4.	Successors and Assigns; Assignment. Except as otherwise expressly limited herein, this Warrant
shall inure to the benefit of, be binding upon, and be enforceable by the Holder and its respective successors, and administrators
and is otherwise non-transferable without the prior consent of the Company. The Holder represents and warrants to the Company that
this Warrant and the Warrant Shares, if and when purchased by the Holder, are for the Holder's own account and for investment purposes
only and not with a view for resale or transfer and that all the rights pertaining to the Warrant or the Warrant Shares, by law
or equity, shall be purchased and possessed by the Holder for the Holder exclusively.

 

		5.5.	Governing Law. This Warrant shall be exclusively governed and construed in accordance with
the laws of the State of New York, without regard to conflicts of laws provisions thereof. The parties hereto agree to submit to
the exclusive jurisdiction of the courts of New York with respect to the breach or interpretation of this Warrant or the enforcement
of any and all rights, duties, liabilities, obligations, powers, and other relations between the parties arising under this Warrant.

 

		5.6.	Notices. All notices and other communications required or permitted hereunder to be given
to a party shall be in writing. All notices shall be given by registered mail (postage prepaid), by facsimile or email or otherwise
delivered by hand or by messenger to the parties' respective addresses as set forth herein and as shall be designated by notice
from time to time. Any notice sent in accordance with this Section shall be deemed received upon the earlier of: (i) if sent by
facsimile or email, upon transmission and confirmation of transmission or (if transmitted and received on a non-business day) on
the first business day following transmission and electronic confirmation of transmission; (ii) if sent by registered mail, upon
3 (three) days of mailing; (iii) if sent be messenger, upon delivery; and (iv) the actual receipt thereof.

 

[the
remainder of this page was intentionally left blank]

 

    	2

    	 

    

 

[Signature Page to Warrant]

 

IN WITNESS WHEREOF,
the Company has caused this Warrant to be executed by its officer thereunto duly authorized.

 

	Dated:  _______________	IMMUNE PHARMACEUTICALS INC.
	 	 	 
	 	By: 	 
	 	 	Name:  Dr. Daniel Teper
	 	 	Title:    Chief Executive officer

 

    	3

    	 

    

 

Schedule 2.1

 

Exercise Notice

 

Date: ____________

 

To:      Immune Pharmaceuticals Inc.

 

The undersigned, pursuant to the provisions
set forth in the Warrant to which this Exercise Notice is attached (the "Warrant"), hereby elects to purchase
_________ Warrant Shares (as such term is defined in the Warrant) pursuant to Section 2.1 of the Warrant, and herewith makes payment
of _____________, representing the full Exercise Price for such shares as provided for in such Warrant.

 

	 	Signature:	 
	 	 	 
	 	Address:	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

    	4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}]]